Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group

Quality functions from pharmaceutical sponsor companies aim to increase the use of analytics in their oversight of Good Clinical Practices and Pharmacovigilance activities. To leverage and accelerate progress, several companies decided to establish a collaborative model. The goals of this collaborat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ménard, Timothé, Young, Kyle, Siegel, Laura, Emerson, Jennifer, Studt, Robert, Sidor, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376133/
https://www.ncbi.nlm.nih.gov/pubmed/34247450
http://dx.doi.org/10.1002/psp4.12677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376133/
https://www.ncbi.nlm.nih.gov/pubmed/34247450
http://dx.doi.org/10.1002/psp4.12677

Ejemplares similares